Latest news with #OrthoPediatrics'
Yahoo
25-03-2025
- Business
- Yahoo
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference
WARSAW, Ind., March 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ('OrthoPediatrics' or the 'Company') (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference. Event: 24th Annual Needham Virtual Healthcare Conference Format: Fireside Chat Date: Tuesday, April 8, 2025 Time: 9:30 am ET An audio webcast of the discussion will be available online at the OrthoPediatrics' investor relations website, Additionally, a replay will be available after the event. About OrthoPediatrics in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 75 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics' global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit Investor ContactPhilip Trip Taylor Gilmartin Groupphilip@
Yahoo
24-03-2025
- Business
- Yahoo
OrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana
WARSAW, Ind., March 24, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ('OrthoPediatrics' or the 'Company') (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it was selected as one of the 2025 Best Places to Work in Indiana. This is the 9th time the Company has been recognized by the annual program created by the Indiana Chamber of Commerce. OrthoPediatrics President & CEO David Bailey commented, 'I'm so proud of our organization for being named one of the 'Best Places to Work' in Indiana for a 9th time. Our leadership team is committed to fostering an engaging and inclusive culture, and meaningful career experiences for all our associates. We are always investing in our people and looking for new and attractive ways to build on what we have created at OrthoPediatrics. It's an honor to know our colleagues feel proud to work for our company and advance our cause of helping KIDS.' The list features honorees from all corners of the state and more than 20 industries. In this 20th edition of the Indiana Chamber of Commerce initiative, a total of 150 companies made the cut. 'We all recognize that currently there is intense competition for talent. This program is a great way for organizations to take the temperature of their culture and how it's resonating with today's workers,' says Indiana Chamber President and CEO Vanessa Green Sinders. 'Companies on the right cultural track also are much more likely to be effective across the board and have increased productivity and overall success. We salute each of this year's winners for their commitment to displaying best practices in their workplaces, which are enabling them to attract and retain employees.' This statewide survey and awards program is designed to identify, recognize, and honor the participating employers in Indiana with the leading workplace cultures. The final rankings will be announced at an awards ceremony on Wednesday, April 30th, 2025, and then published in the Indiana Chamber's BizVoice® magazine after the event. For more information on the Best Places to Work in Indiana program, visit: About OrthoPediatrics in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 75 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics' global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit Investor ContactPhilip Trip TaylorGilmartin Groupphilip@ in to access your portfolio
Yahoo
08-03-2025
- Business
- Yahoo
Earnings Update: OrthoPediatrics Corp. (NASDAQ:KIDS) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Investors in OrthoPediatrics Corp. (NASDAQ:KIDS) had a good week, as its shares rose 9.2% to close at US$25.35 following the release of its annual results. Revenues were in line with expectations, at US$205m, while statutory losses ballooned to US$1.64 per share. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results. Check out our latest analysis for OrthoPediatrics Following the latest results, OrthoPediatrics' six analysts are now forecasting revenues of US$239.1m in 2025. This would be a meaningful 17% improvement in revenue compared to the last 12 months. Losses are expected to be contained, narrowing 18% from last year to US$1.28. Before this latest report, the consensus had been expecting revenues of US$240.8m and US$1.10 per share in losses. While this year's revenue estimates held steady, there was also a noticeable increase in loss per share expectations, suggesting the consensus has a bit of a mixed view on the stock. As a result, there was no major change to the consensus price target of US$39.00, with the analysts implicitly confirming that the business looks to be performing in line with expectations, despite higher forecast losses. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on OrthoPediatrics, with the most bullish analyst valuing it at US$50.00 and the most bearish at US$26.00 per share. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business. Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. We would highlight that OrthoPediatrics' revenue growth is expected to slow, with the forecast 17% annualised growth rate until the end of 2025 being well below the historical 22% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 7.8% annually. Even after the forecast slowdown in growth, it seems obvious that OrthoPediatrics is also expected to grow faster than the wider industry. The most important thing to take away is that the analysts increased their loss per share estimates for next year. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. The consensus price target held steady at US$39.00, with the latest estimates not enough to have an impact on their price targets. Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for OrthoPediatrics going out to 2027, and you can see them free on our platform here.. We don't want to rain on the parade too much, but we did also find 1 warning sign for OrthoPediatrics that you need to be mindful of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
19-02-2025
- Business
- Yahoo
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
WARSAW, Ind., Feb. 19, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ('OrthoPediatrics' or the 'Company') (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, March 4, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event. About OrthoPediatrics in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 75 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics' global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit Investor ContactPhilip Trip TaylorGilmartin Groupphilip@ 415-937-5406Sign in to access your portfolio
